• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Long-term effect of sotalol on plasma lipids.

作者信息

Lehtonen A, Viikari J

出版信息

Clin Sci (Lond). 1979 Dec;57 Suppl 5:405s-407s. doi: 10.1042/cs057405s.

DOI:10.1042/cs057405s
PMID:232028
Abstract
  1. We studied the effect on plasma lipids of sotalol given orally over a 12 month period to patients with essentially hypertension. 2. Plasma free fatty acid concentration was lower than initially at 1, 3, 6 and 12 months. The difference was significant (P less than 0.01) at 1 and 3 months. 3. Plasma cholesterol (VLDL + LDL-cholesterol) increased during treatment. Plasma total cholesterol increased from 5.49 +/- SD 0.94 mmol/l at the beginning to 6.37 +/- 1.10 mmol/l at 12 months (P less than 0.01). 4. HDL-cholesterol concentration and the ratio of HDL-cholesterol to total cholesterol decreased significantly. The ratios were 0.28 and 0.18 at the beginning and at 12 months respectively (P less than 0.001). 5. Plasma triglycerides increased simultaneously from 1.14 +/- 0.31 to 1.89 +/- 0.99 mmol/l (P less than 0.01).
摘要

相似文献

1
Long-term effect of sotalol on plasma lipids.
Clin Sci (Lond). 1979 Dec;57 Suppl 5:405s-407s. doi: 10.1042/cs057405s.
2
[Adrenergic mechanisms and their significance for plasma lipid concentrations].[肾上腺素能机制及其对血浆脂质浓度的意义]
Wien Med Wochenschr. 1982;132 Spec No 2:19-22.
3
Adrenergic mechanisms in control of plasma lipid concentrations.控制血浆脂质浓度的肾上腺素能机制。
Br Med J (Clin Res Ed). 1982 Apr 17;284(6323):1145-8. doi: 10.1136/bmj.284.6323.1145.
4
Plasma testosterone and serum lipids in male survivors of myocardial infarction.心肌梗死男性幸存者的血浆睾酮与血脂
J Steroid Biochem. 1976 Mar;7(3):229-31. doi: 10.1016/0022-4731(76)90206-5.
5
Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.烟浪丁(季戊四醇四烟酸酯)对血浆脂蛋白浓度的影响:低高密度脂蛋白血症中高密度脂蛋白(HDL)胆固醇及HDL胆固醇/低密度脂蛋白胆固醇比值的升高
Artery. 1982;10(4):266-85.
6
Effect of chronic administration of propranolol on lipoprotein composition.慢性给予普萘洛尔对脂蛋白组成的影响。
Metabolism. 1976 Oct;25(10):1071-5. doi: 10.1016/0026-0495(76)90014-7.
7
Moderate ethanol ingestion and plasma triglyceride levels. A study in normal and hypertriglyceridemic persons.
Ann Intern Med. 1974 Feb;80(2):143-9. doi: 10.7326/0003-4819-80-2-143.
8
The effect of nifedipine on plasma lipids in patients with essential hypertension.
Int J Clin Pharmacol Ther Toxicol. 1986 Jul;24(7):357-8.
9
Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.芦丁对链脲佐菌素诱导的糖尿病大鼠脂质、脂蛋白、脂质代谢酶和糖蛋白的保护作用。
J Pharm Pharmacol. 2006 Oct;58(10):1373-83. doi: 10.1211/jpp.58.10.0011.
10
Effects of amount and type of dietary fat on serum lipids, lipoproteins and apolipoproteins in man. A controlled 8-week trial.膳食脂肪的量和类型对人体血清脂质、脂蛋白和载脂蛋白的影响。一项为期8周的对照试验。
Atherosclerosis. 1980 Aug;36(4):515-27. doi: 10.1016/0021-9150(80)90244-0.

引用本文的文献

1
Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.索他洛尔。其药理特性及在心律失常治疗应用中的最新综述。
Drugs. 1993 Oct;46(4):678-719. doi: 10.2165/00003495-199346040-00007.
2
Effects of pindolol and metoprolol on plasma lipids and lipoproteins.吲哚洛尔和美托洛尔对血脂及脂蛋白的影响。
Br J Clin Pharmacol. 1982;13(Suppl 2):435S-439S. doi: 10.1111/j.1365-2125.1982.tb01953.x.
3
Beta-blocker induced changes in the cholesterol: high-density lipoprotein cholesterol ratio and risk of coronary heart disease.
β受体阻滞剂引起的胆固醇与高密度脂蛋白胆固醇比值变化及冠心病风险
Klin Wochenschr. 1984 Sep 17;62(18):843-9. doi: 10.1007/BF01711998.
4
HDL cholesterol and beta-adrenoceptor blocking agents in a 5 year multifactorial primary prevention trial.在一项为期5年的多因素一级预防试验中的高密度脂蛋白胆固醇与β-肾上腺素能受体阻滞剂
Br J Clin Pharmacol. 1982;13(Suppl 2):431S-434S. doi: 10.1111/j.1365-2125.1982.tb01952.x.
5
Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.吲哚洛尔——一种具有部分激动剂活性的β-肾上腺素能受体阻滞剂:临床药理学考量
Br J Clin Pharmacol. 1982;13(Suppl 2):187S-192S. doi: 10.1111/j.1365-2125.1982.tb01909.x.
6
Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.索他洛尔。对其药效学和药代动力学特性以及治疗用途的综述。
Drugs. 1987 Sep;34(3):311-49. doi: 10.2165/00003495-198734030-00002.
7
Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients.高血压患者长期使用吲哚洛尔或阿替洛尔治疗的代谢效应比较。
Cardiovasc Drugs Ther. 1988 Jan;1(5):549-51. doi: 10.1007/BF02125739.
8
Effects of acebutolol on the serum lipid profile.
Drugs. 1988;36 Suppl 2:41-50. doi: 10.2165/00003495-198800362-00008.
9
The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.抗高血压药物对血脂和脂蛋白的影响。II. 非利尿药物。
Drugs. 1986 Oct;32(4):335-57. doi: 10.2165/00003495-198632040-00003.
10
The effects of diuretics and adrenergic-blocking agents on plasma lipids.利尿剂和肾上腺素能阻滞剂对血浆脂质的影响。
West J Med. 1986 Aug;145(2):210-8.